Benzinga's Top #PreMarket Losers

AcelRx Pharmaceuticals, Inc. ACRX shares fell 46.11% to $4.71 in pre-market trading. AcelRx received an FDA update regarding the NDA application for Zalviso. BlackBerry Limited BBRY shares declined 3.94% to $10.25 in pre-market trading. Goldman Sachs downgraded BlackBerry to Sell and lowered the price target from $10.00 to $9.00. Orexigen Therapeutics, Inc. OREX shares dropped 2.82% to $6.90 in pre-market after falling 11.36% on Friday. Michael Kors Holdings LimitedKORS fell 2.23% to $64.51 in pre-market trading after dropping 1.73% on Friday. McDonald's Corp. MCD shares dropped 1.16% to $96.00 in pre-market trading after the company reported a 1.7% drop in its global comparable sales in February.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsConsumer DiscretionaryRestaurantsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!